SANCC: Clinical Trial Early Intervention

NCT03950037 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to complete due to SARS-CoV-2 pandemic

Conditions

Subarachnoid Neurocysticercosis

Interventions

DRUG: Albendazole

Sponsor

Oregon Health and Science University

Collaborators

[object Object]
[object Object]